— That's because you call yourself an evolutionary biologist. However, bioinformaticians are opportunists by definition.
— Yes, indeed. I hope that we also bring a fundamental component — evolutionary biology — into these opportunistic relationships. Since, you know, "nothing in biology makes sense except in the light of evolution". And we always try to follow that principle. So fifty-fifty is me being a bit flattering to myself. There might actually be 60% opportunism if you look more closely.
— What's the most interesting thing that has been happening in evolutionary biology lately? And what are you most pleased with? What were you best at?
— Let's start with things done by other scientists. Here, I'm most interested in experimental evolution. I'm talking, of course, about the works of Richard Lenski, but not only him. There are now many others. It's also incredibly fascinating to see how different phenomena — selection, fixation of something random and non-random, the so-called clonal interference, and replacement of one lineage by another — manifest in actual experiments. It's fascinating to observe.
As for my own field of study... Quite a lot has actually happened over the last five years, and I might sound a bit presumptuous here. As I said in my talk at a recent conference, I think that, to my own surprise, we've managed to basically figure out the history of viruses. How all the diversity that we see today evolved and how it is structured. Our understanding has clarified, which I myself was very struck by. Everything fits into place without falling apart. It's beautiful.
— Do you expect no fundamentally new viral polymerases to be discovered?
— I expect exactly that. I can predict which polymerases that the hosts already have could be hijacked and utilized by some fairly rare viruses (because if they weren't rare, we'd already know about it). But there are no fundamentally new polymerases, and there won't be any.
On the other hand, since we've touched upon the issue of diversity versus unity, there are all sorts of amazing discoveries in which we have participated... But not to boast too much, I should also mention the others. There is, in particular, Rotem Sorek from the Weizmann Institute. He is quite remarkable. He and I both study the diversity and evolution of bacterial immunity systems and defenses against viruses and other genetic parasites. And here we observe a number of absolutely astonishing phenomena. Combinatorial diversity is made up of a relatively small number of building blocks, which one might call elementary particles, while the number of combinations is incredibly large. It's like what happened in organic chemistry. Atoms are few, but together they make up a whole big world.
— You deal with the deepest evolutionary stories imaginable. Viruses are the most complete evolutionary reconstruction there is. The only thing deeper than that is the origin of the genetic code, which you have also touched upon.
— It's a complex but important issue. I'm thinking of speaking about something that goes even further back.
— Well, that's the deepest we can go. In normal, cellular life we can't go any further than LUCA. But with viruses you apparently do go further.
— That's not quite correct. You can look much deeper into history.
— On the other hand, you say the most interesting thing going on right now is evolutionary experiments, which study short-term and recent events. How can you be interested both in deep and shallow evolution?
— That's another excellent question. I can, and it's even much deeper than we discussed — up to theories that encompass evolution in general (not only biological). But I am interested in the entire spectrum of evolution. I like it. I intentionally live and act that way.
— On what exactly do you think we should focus our attention in evolutionary biology at the moment? What is the most fascinating point?
— It's the study of bacterial and archaeal diversity in connection with the origin of eukaryotes. The discovery of Asgard archaea, which are almost undeniably the closest known relatives of eukaryotes, is profoundly significant. And the story continues. It's entirely plausible that we'll find even closer relatives and gain some insight into how and when endosymbiosis occurred.
Metagenomics is equally fascinating. It's a quietly ongoing revolution from which an increasing number of ideas and knowledge are being drawn. Our understanding of all viruses and their evolutionary history is rooted in metagenomics. Of course, it's not solely based on it, but it is what leads us to believe that we are conducting a comprehensive sampling. There, key discoveries are made, such as a large number of bacteria and archaea that are now clearly symbionts or parasites of other bacteria and archaea. This was known but seemed incredibly exotic, and now it is quite clear that these things are exceptionally widespread but hard to detect.
It's fascinating to follow (this again relates to the field of diversity, but in a slightly different context) the discovery of various unicellular eukaryotes, which are so exotic that few would find them uninteresting. Bacteriophages, which are abundant in our guts and other places, have genes that are expressed in ways we don't yet understand. Some of the genes in these phages are fragmented beyond recognition. Sure, there are plenty of introns and inteins, but there is something else there too. Something incredibly peculiar is happening — some sort of pathways for expression and, so to speak, mRNA assembly. There is a level of molecular biology at play that we don't yet fully comprehend.
— Are there any areas of evolutionary biology or the aforementioned bioinformatics that you find uninteresting or difficult to grasp?
— The word "uninteresting" is inapplicable when discussing evolutionary biology. As for what I struggle to grasp, it's everything that falls under ‘evolution and development’, i.e., the evolution of multicellular organisms and particularly the details of their development.
— Why is that?
— It's really difficult to tell. There are factors at play like... continuity, history, and chance.
— Was there no one to perform omics research twenty years ago because you didn't find the right people, and then it just took off from there?
— Something like that.
— Evo-devo relies heavily on omics technologies.
— It didn't pan out for me. Not that I wanted it to. Besides, there was no data available. On the other hand, evo-devo involves understanding biology at a level of complexity that utterly intimidates me. I want to have at least some understanding of what we're doing. When I look at a book by Eric H. Davidson — may that remarkable person rest in peace — the diagrams I see there fill me with absolute dread. They can be drawn, but I don't believe they can be explained in understandable terms. I don't want to engage in that.
— Maybe you just don't like meat grinders.
— I'm not particularly fond of them either. On the other hand, what area of bioinformatics interests me? Frankly, there are almost no such areas.
— In this context, bioinformatics is a tool. It doesn't consist of areas, just like electron microscopy.
— I disagree. Both of them have areas of genuine, serious research. There are remarkable people who are interested in algorithms.
— Those remarkable people are doing a good job creating a new microscope for us.
— There are individuals who have rightfully earned their Nobel Prizes for creating new microscopes.
— What could a Nobel Prize in evolutionary biology or bioinformatics be awarded for?
— In evolutionary biology, probably for nothing, because it doesn't fit into Nobel Prize categories. It's neither medicine or physiology nor chemistry. As for what a Nobel Prize in bioinformatics could be awarded for, I have a very clear idea. I even have some specific insider knowledge. Without a doubt, it should be awarded for sequence similarity search programs... Sequence similarity database screening, FASTA, BLAST, and so on.
— About twenty years ago, Jim Fickett and I were debating what a Nobel Prize in mathematical biology could be awarded for, and we thought of protein structure.
— Yes, also for that to some extent.
— So should the Nobel Prize be awarded to Google?
— Michael Levitt has already been awarded the Nobel for some versions of structural modeling. Google and David Baker certainly deserve a prize too. But on the other hand, it's unfair because sequence comparison in practice, at least for now, is much more important. It's what the whole world relies on.
— Are Nobel prizes in biology actually necessary? Do they make sense? After all, it always turns out that, in addition to the two or three people who get the prize, there are half a dozen others who should also be awarded for the same discovery...
— With very few exceptions, that's how it usually goes, yes. And those exceptions happened a while ago. I think we need to be more relaxed about it. We should give prizes but not make a fetish of them. After all, it is clearly written in Nobel's will that they are given for specific discoveries or inventions. That's just the way it is. You shouldn't think that whoever got them is a great scientist and whoever didn't is not.
— Let's take CRISPR-Cas, for example. The award was given to the scientists who figured out how to use CRISPR-Cas for genetic engineering. However, prior to that, there were the remarkable people from Danisco who experimentally demonstrated that CRISPR-Cas is a form of anti-phage immunity. Before that, you and your colleagues had predicted it, and even before that, Francisco Mojica had spent a decade collecting repeats in bacterial genomes and even observed phage insertions in them. And even earlier, some forgotten Japanese researchers were the first to describe such repeats...
— Of course, all these people deserve some sort of reward.
— In other words, the award was given, as Alfred Nobel intended, not for a discovery but for an invention. However, adaptive bacterial immunity is a discovery, and it's as fundamental as it gets.
— Absolutely correct.
— So who is to be commended?
— Everyone! Certainly, another prize could be awarded for these discoveries in physiology and medicine. It's not entirely impossible for this to happen, but I find it highly unlikely. Both groups have done well. Once again, awards should be given as they stimulate progress rather than hinder it, but there is no need to fret over it.
— What should we fret over, then?
— We should fret over understanding of how the world functions.
— Is there something we will never comprehend in evolutionary biology?
— Of course! The answer is simple. We will never comprehend how life originated. We can construct a beautiful theory to some extent and develop good chemistry, but it's very challenging. Not only I, but even you won't witness it. But, theoretically, if everything goes well and humanity survives, then maybe in a hundred years we might create a functioning cell in a lab. I'm not completely ruling that out. But how it actually happened, that no one will ever find out.